Onesource Specialty Pharma Ltd. — documents
32 files on disk. SHA-256 from the acquisition manifests; links open the exchange copy.
| Class | Period | Scope / kind | Filing date | File | SHA-256 |
|---|---|---|---|---|---|
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_119366_1376460_10022025040527.xml | 3d6d38911fe13373 |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_119367_1376466_10022025040723.xml | 3124a76ce26e53ca |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_118078_1365194_29012025080407.xml | 50087b31f8819d13 |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_118079_1365197_29012025080507.xml | 40d6b6bde81b7ce5 |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1431876_05052025 | 76e1d96f7727ee2d |
| Results XBRL (NSE) | 2025-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1431877_05052025 | d54122842ca26b9b |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1502221_04082025 | aaf651df8904b454 |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1502226_04082025 | 53eede4bd2fda180 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1571385_11112025 | 25fceb4e2a9b8a0e |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1571398_11112025 | 9963f400ded88ef8 |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1609645_23012026 | d05f5f13305d8663 |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1609646_23012026 | 4d03440cb2120cbc |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1666607_13052026 | 06f18dad5787bec3 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1666609_13052026 | 73b1e69d3a829810 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1666611_13052026 | 73b1e69d3a829810 |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1701209_24072026 | ff44a5e541de4433 |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1701210_24072026 | e8c574e08b89c0b1 |
| Annual report | 2025-03-31 | grade A | 2025-08-29T18:20:06.087 | bc7ae255-5594-44e0-acf6-1b6c228a3a31.pdf | 5eae370d6fed909b |
| Annual report | 2026-03-31 | grade A | 2026-08-31T20:32:25.133 | 5791fc38-5d57-4709-bc0a-92a61486428c.pdf | 8f75960fb86d26db |
| Concall | 2025-03-31 | TRANSCRIPT | — | Date_20250512_Onesource Specialty Pharma Ltd._Concal_Q4FY25. | 4fe4e243841df7fc |
| Concall | 2025-06-30 | TRANSCRIPT | — | Date_20250812_Onesource Specialty Pharma Ltd._Concal_Q1FY26. | 877fa4c874a51854 |
| Concall | 2025-09-30 | TRANSCRIPT | — | Date_20251118_Onesource Specialty Pharma Ltd._Concal_Q2FY26. | 8aecd3da91e3dfa4 |
| Concall | 2026-03-31 | TRANSCRIPT | — | Date_20260519_Onesource Specialty Pharma Ltd._Concal_Q4FY26. | 60400a3a0726e37b |
| Concall | 2026-06-30 | TRANSCRIPT | — | Date_20260731_Onesource Specialty Pharma Ltd._Concal_Q1FY27. | f40ad8abcc548891 |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_1490386_22072025043651_WEB.xml | 9c0c005542d252d1 |
| Shareholding XBRL | 2025-01-24 | — | — | SHP_196097_1361111_25012025123534_WEB.xm | 7aa8d78ff2a0c54f |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_1490398_22072025044341_WEB.xml | f1336cc067d6d9d8 |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1488675_21072025030335_WEB.xml | 6908eb11f2c32ce6 |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1554157_19102025084029_WEB.xml | c6a90cd026d59771 |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1605870_20012026052826_WEB.xml | b5897af2019cd91d |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1655101_20042026045414_WEB.xml | 7c469931131f7a96 |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1698877_21072026080714_WEB.xml | 24a50e1d5cae3d82 |